Japan, Jan. 16 -- INOTREM has got intellectual property rights for 'USE OF SOLUBLE TREM-1 LEVELS FOR IDENTIFYING SUBJECTS SUSCEPTIBLE TO RESPOND TO ANTI-INFLAMMATORY THERAPY.' Other related details are as follows:
Application Number: JP,2024-011668
Category (FI): A61K38/10,A61P29/00,A61P31/04,A61P37/00,G01N33/53@D
Stage: Grant (IP right granted following substantive examination.)
Filing Date: Jan. 30, 2024
Publication Date: April 23, 2024
The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100
Disclaimer: Curated by HT Syndication.
